Autologous bone marrow transplantation is suitable for patients mainly with lymphoma, multiple myeloma, acute leukemia with relatively low risk and malignant tumors such as neuroblastoma; and benign diseases, such as refractory rheumatoid arthritis, systemic lupus erythematosus, idiopathic thrombocytopenic purpura, pure red remittance, etc. The treatment process is divided into the following stages: 1. Autologous bone marrow transplantation collection, nowadays, is the collection of peripheral blood stem cells Most of them use high-dose chemotherapy, followed by whitening injections and mobilizers, and wait for the check of peripheral blood picture to rise after the collection through the machine blood cell separator, which is almost the same process as hemodialysis. The patient or donor lies in bed for about 4 hours, and the collection process is generally safe and painless; 2. After collection, the collected seed cells need to be frozen in the laboratory for backup; 3. After the patient enters the sterile warehouse ward, high-dose chemotherapy is administered for about 5-10 days, and then the frozen seed cells are retrieved from the laboratory, revived in warm water, and transfused back into the patient’s body through a vein like a blood transfusion, and waiting for the hematopoiesis to recover. In about 2-3 weeks, the white blood cells and platelets gradually return to normal. There is a standardized follow-up monitoring plan after discharge, and the follow-up is about 2 years or more with regular outpatient checkups and treatments.